IL2 and neoplasm: Previously, we showed that AP-EVs displaying pMHCII with cytokines such as IL−2, IL−12, or IL−4 can expand antigen-specific T cells and enhance anti-tumor immunity (Kimura et al., 2025; Lyu et al., 2025).